Literature DB >> 18346286

Modelling alternative strategies for delivering hepatitis B vaccine in prisons: the impact on the vaccination coverage of the injecting drug user population.

A J Sutton1, N J Gay, W J Edmunds, O N Gill.   

Abstract

Since 2001 hepatitis B vaccination has been offered to prisoners on reception into prisons in England and Wales. However, short campaigns of vaccinating the entire population of individual prisons have achieved high vaccination coverage for limited periods, suggesting that short campaigns may be a preferable way of vaccinating prisoners. A model is used that describes the flow of prisoners through prisons stratified by injecting status to compare a range of vaccination scenarios that describe vaccination on prison reception or via regular short campaigns. Model results suggest that vaccinating on prison reception can capture a greater proportion of the injecting drug user (IDU) population than the comparable campaign scenarios (63% vs. 55.6% respectively). Vaccination on prison reception is also more efficient at capturing IDUs for vaccination than vaccination via a campaign, although vaccination via campaigns may have a role with some infections for overall control.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18346286      PMCID: PMC2870786          DOI: 10.1017/S0950268808000502

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  12 in total

1.  Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.

Authors:  A R Weild; O N Gill; D Bennett; S J Livingstone; J V Parry; L Curran
Journal:  Commun Dis Public Health       Date:  2000-06

Review 2.  Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention.

Authors:  Cindy M Weinbaum; Keith M Sabin; Scott S Santibanez
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

3.  Increasing hepatitis B vaccine coverage in prisons in England and Wales.

Authors:  R L Gilbert; A Costella; M Piper; O N Gill
Journal:  Commun Dis Public Health       Date:  2004-12

4.  Hepatitis A vaccination--a prison-based solution for a community-based outbreak?

Authors:  R L Gilbert; T O'Connor; S Mathew; K Allen; M Piper; O N Gill
Journal:  Commun Dis Public Health       Date:  2004-12

5.  Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.

Authors:  S Allwright; F Bradley; J Long; J Barry; L Thornton; J V Parry
Journal:  BMJ       Date:  2000-07-08

6.  Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons.

Authors:  Sharon J Hutchinson; Sarah Wadd; Avril Taylor; Sheila M Bird; Alan Mitchell; David S Morrison; Syed Ahmed; David J Goldberg
Journal:  Vaccine       Date:  2004-11-25       Impact factor: 3.641

7.  Anonymous HIV surveillance with risk-factor elicitation: at Perth (for men) and Cornton Vale (for women) prisons in Scotland.

Authors:  S M Gore; A G Bird; S Burns; A J Ross; D Goldberg
Journal:  Int J STD AIDS       Date:  1997-03       Impact factor: 1.359

8.  Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie.

Authors:  A G Bird; S M Gore; S Cameron; A J Ross; D J Goldberg
Journal:  AIDS       Date:  1995-07       Impact factor: 4.177

9.  Modelling the hepatitis B vaccination programme in prisons.

Authors:  A J Sutton; N J Gay; W J Edmunds; N J Andrews; V D Hope; R L Gilbert; M Piper; O N Gill
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

10.  Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.

Authors:  A J Sutton; N J Gay; W J Edmunds; V D Hope; O N Gill; M Hickman
Journal:  BMC Infect Dis       Date:  2006-06-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.